Purpose: To develop an automated treatment planning strategy for external beam intensity-modulated radiation therapy (IMRT), including a deep learning-based three-dimensional (3D) dose prediction and a dose distribution-based plan generation algorithm. Methods and Materials: A residual neural network-based deep learning model is trained to predict a dose distribution based on patient-specific geometry and prescription dose. A total of 270 headand-neck cancer cases were enrolled in this study, including 195 cases in the training dataset, 25 cases in the validation dataset, and 50 cases in the testing dataset. All patients were treated with IMRT with a variety of different prescription patterns. The model input consists of CT images and contours delineating the organs at risk (OARs) and planning target volumes (PTVs). The algorithm output is trained to predict the dose distribution on the CT image slices. The obtained prediction model is used to predict dose distributions for new patients. Then, an optimization objective function based on these predicted dose distributions is created for automatic plan generation.
INTRODUCTION
Intensity-modulated radiation therapy (IMRT) is the most common method of external beam radiation treatment for many cancers such as prostate, head-and-neck, and lung tumors. 1, 2 Although IMRT has been widely used and computational improvements have been made, the planning process which is tuned in a trial and error approach still involves nonintuitive, iterative steps based on planners' subjective decisions and relies on planners to convert clinical intent to dose-volume histogram (DVH)-based objectives and their priorities. Planners can expend days to produce treatment plans, yet the resulting plan quality might be highly variable between planners due to variations in the accuracy of DVH objective placement and its relative priority. Inconsistent plan quality not only implies that the full potential of the radiotherapy treatment is not consistently achieved but also suggests the possibility of compromised patient care. [3] [4] [5] A number of efforts in assisting treatment planning using knowledge-based techniques, including RapidPlan in Eclipse, 6, 7 Multi-Criteria Optimization in RaySearch, 8 and AutoPlan in Pinnacle, 9 have improved consistency of plan quality. Utilizing prior knowledge of achievable DVHs can automatically estimate target DVH objectives for the inverse-planning optimization. [10] [11] [12] However, these methods cannot provide any reasonable estimation on patient-specific achievable dose distributions. Consequently, planner does not have specific control over where to avoid or allow irradiation within a contoured structure. Because a large number of dose distributions satisfy the same DVH objectives, this may result in plans with acceptable DVH objectives but unacceptable dose distributions in some specific clinical concerned area.
In this paper, we present a method for 3D dose prediction using deep learning method for head-and-neck cancer patients. We realize precise estimations of dose distribution using a deep residual neural network trained on images describing patient geometry and manually optimized dose distributions. This knowledge-based system can not only provide estimation on DVH objectives but also give voxel-level feedback to planners about where the dose distribution could be improved. We then perform voxel-by-voxel dose optimization using the predicted voxel. This optimization does not require any specific dose-volume objectives. An independent modified treatment planning system (TPS) based on the radiation treatment planning toolkit matRad 13 was used to show the feasibility of our method.
We describe the dataset used in Section 2.A and the deep learning-based 3D dose distribution prediction is discussed in Section 2.B. The voxel-by-voxel dose optimization is presented in Section 2.C. Results are shown in Sections 3 and discussions are in Section 4.
MATERIALS AND METHODS
A Residual Network (ResNet) 14 -based framework is trained to correlate voxel geometry to voxel dose for the prediction of the achievable dose matrix for a given patient anatomy. The image representing the patient anatomy in each trans-axial CT slice is the input data for the network. The output of the network is the dose matrix for this given slice. The automatic generated plan (Auto plan) is optimized based on these predicted dose distributions and compared to the manually optimized plan and the predicted plan (Pred plan). A flowchart of this automatic planning process is shown in Fig. 1 .
2.A. Patients and treatment plans
In this study, a dataset of 270 head-and-neck patients undergoing radiotherapy was utilized. The delivered IMRT plans, which used nine beam step-and-shot with equal beam angle spacing, were generated by experience dosimetrists using the Pinnacle 3 treatment planning system (Philips Medical System, Madison, WI, USA). The dataset used in this study consists of patients with different prescription doses as summarized in Fig. 2 . The whole dataset was randomly separated into the training set with 195 cases, the validation set with 25 cases and the testing set with 50 cases. The patients in the testing set are also used in the voxel-by-voxel treatment planning described in Section 2.C. The open source platform Visualization Toolkit 15 was used to extract the images representing patient's anatomy and dose matrix for each trans-axial slice of the CT. Besides the CT images, two other delineation images, as shown in Fig. 3 , were input into the prediction model. The first was the PTV delineation image, which described the region, shape, and size of PTVs. The prescribed doses were filled as the pixel value for each PTV. In other words, this image represents an ideal dose distribution. The second image described the shape, size, and relative position for OARs. A value was assigned to each pixel in order to designate the organ to which it belonged. Twelve OARs were included as the input of the model training. These organs were the brainstem, spinal cord, right and left parotid glands, right and left temporal lobes, right and left lens, right and left optic nerves, chiasm, and oral cavity. In the second image, the body region was also considered and a common value was assigned to each pixel inside the body that was not within OARs. The pixels outside the body were assigned a pixel value of zero. In addition, the dose distribution (calculated from TPS) image corresponding to this anatomical structure is the outcome for the model training process. In conclusion, each training sample included one CT image, two delineation images, and one dose distribution image.
Considering the fact that the dose is dependent on the spatial distance between PTVs and OARs, all these images were rescaled to identical pixel size of 2.5 mm 9 2.5 mm and trimmed into 256 9 256 pixels. The scientific computing package NumPy 16 was used to process all these images. In order to account for the dependence on the anatomical geometry in the adjacent region of the given anatomy, another six anatomical images which locate in the superior and inferior region are also considered in the dose matrix prediction for this given anatomy. All these anatomical images are treated as different channels of the input layer when fed into the learning network.
2.B.2. Dose distribution prediction framework and model training
After the image datasets were acquired, we developed a regression system that uses ResNet with a depth of 50 layers (ResNet50).
14 The architecture of the ResNet consists of a stack of similar (so-called residual) blocks, each block being in turn a stack of convolutional layers. The innovation of this architecture is that the output of a block is also connected with its own input through an identity mapping path. This alleviates the gradient vanishing problem, improving the gradient backward flow in the network and allows to train much deeper networks. The extremely deep ResNet has excellent generalization performance and won the ImageNet Large Scale Visual Recognition Challenge in 2015. 17 The network architecture of the regression system is a socalled "ResNet-antiResNet" architecture. It is established on the RestNet and "antiRestNet" which has inversed ResNet structure. Figure 4 illustrates the network architecture used in this analysis. Deconvolutional layers 18 were implemented in the "antiRestNet" structure to upsample the feature maps and recover the image details. We further propose to link convolutional and deconvolutional layers with multiple skip-layer connections. The skip connections tackle the problem of gradient vanishing and the recovery of the clean image also benefits from the image details passed from convolutional layers to deconvolutional layers. 19 Rectified Linear Unit (ReLU) 20 was used as the activation function in both the up-and downsampling paths. In Section 3, we show that better performance is achieved with the proposed network architecture.
The python deep learning library Keras 21 with the TensorFlow 22 backend was applied to establish this regression system and an NVIDIA GeForce GTX 1080 is the GPU used for training the model. Performing deep learning with small datasets can be particularly challenging, as a small training set can easily result in problematic overfitting. 23 One way to protect against overfitting is to perform dataset augmentation. 24 By applying distortions to images in the training set with some probability, the size of the training set is effectively increased. In each training epoch, two halves of the total images are randomly picked and one half is flipped along x-axis, while another half is shifted randomly along x and y axis (within forty pixels) simultaneously. The size of the original training set was doubled after augmentation and the augmented datasets are different between each training epoch which guarantees that the network learning process can perform well.
The neural network is trained from randomly initialized weights instead of using pretrained initialization. The Adam 25 optimizer was implemented as a solver to perform the parameter update for each training sample. Because deeper architecture takes up more space on the GPU VRAM, the batch size was set to eight according to the layer depth of network architecture. The learning rate 0.0001 was applied to train the network. The final model was chosen at the training epoch when the loss on the validation set stopped decreasing which guarantees that model stopped learning image features and prevented overfitting on the training data. This final model was then run on the testing set to assess its performance, the results of which are presented in Section 3. While training is time consuming and computationally expensive, testing a single patient with the regression system takes significantly less time (up to 10 s), making clinical deployment possible.
2.C. Dose distribution-based automatic treatment planning
The matRad software, which is an open source cross-platform radiation treatment planning toolkit written in Matlab, was used to implement the automatic treatment planning based on the predicted dose distribution. A fluence mapbased optimization algorithm named interior point optimizer package (IPOPT), which is detailed in Ref. [13] , is used in matRad.
Patients' CT, structure files, and predicted dose distributions were imported to matRad. Then these patients were automatically planned with nine equiangular beams. A target named "PTVs" containing all the PTVs with different prescription doses was utilized to generate beam geometry describing the placement of beamlets. Besides that no further contour delineation is required under this strategy. As an orientation study, we applied a simple objective function to all voxels indifferently. The objective function trying to pull dose in each voxel to its predicted value is shown in Eq. (1). Here
2.D. Performance evaluation
The predictive ability of the deep learning model was evaluated by comparing both the predicted dose distributions and the predicted DVH curves with the TPS calculated results. The average deviations, between the prediction and TPS calculated results, of the OAR and PTV clinical indices for fifty patients which are not included in the training and validation dataset, are compared and summarized in Section 3. A large number of testing plans was used in order to test a range of different prescription patterns. Similarly, the ability of our Auto plan was investigated by comparing dose distributions and clinical indices values with the Pred plan.
RESULTS
To illustrate the performance of this regression system, the clinical and predicted dose distributions for four trans-axial slices that contains different PTVs and OARs are compared in this study. In general, it is observed that a deep learning framework can predict dose distributions without significant differences except for the cavity and marginal area.
Since the deep learning framework can account for varying proximity to multiple PTVs and OARs simultaneously, it is expected that DVH prediction also benefits from the inclusion of all spatial information in the regression system. As can be seen from Figs. 5(m) and 5(n), DVH curves for PTVs and 12 OARs have acceptable agreement between clinical and predicted results for patient A. The same conclusion can be drawn for patient B shown in Appendix A. Figure 6 shows the dose distributions of patient A, including the Pred plan (a, d, g, j) and the Auto plan (b, e, h, k) generated using our new method. We can clearly see, from pixelwise difference maps (c, f, i, l), that the absolute pixel-wise differences between the Pred and Auto plan are all within 5 Gy except for the marginal region. As can be seen from Figs. 6(m) and 6(n), the DVH curves have approximately identical shapes in the Pred and Auto plan for patient A. The corresponding figures for patient B can be found in Appendix B. Table I summarizes the average and standard deviation values of specific clinical indices, for PTVs and OARs from manually optimized plans, Pred plans, and Auto plans in 50 head-and-neck patients. The t-test is applied to test the consistency hypothesis on these values for each clinical indices, respectively. We find that these results are highly comparable except for a few indices which are highlighted in the table.
Compared to the manually optimized plan, the absolute differences of average values for these indices are relatively negligible in the Pred and Auto plan which confirm the feasibility of our proposed method.
DISCUSSION
In this study, a new automated treatment planning strategy based on 3D dose prediction and voxel-by-voxel dose optimization was developed. It is the first to implement a deep learning method to perform an accurate prediction of the 3D dose distribution in head-and-neck cancer patients. Besides the DVH curves, this method also provides voxel-level dose prediction using deep learning technique. It indicates that this method steps forward and provides more information for clinical evaluation compared to current commercial ones using the DVH-based approach. This method is robust even though complicated PTV-OAR relationships, variable PTV shapes and different PTV prescription doses are presented. This is mainly because the proposed network uses most of the information in the images which is the distinctive feature of this new method compared to related previous work. Another unique aspect of this study is that patients with different prescription doses can be trained and predicted in a single deep learning framework.
The proposed method, in particular, can train and predict patients with several PTVs which have different prescription doses. In particular, we can still get acceptable prediction for prescription doses that are not included in the training set, such as prescription [7040, 6000, 5400] and [6000, 5400, 5100] shown in Fig. 2 . We believe that this is the distinctive feature of this method that has not been investigated in previous work. Meanwhile, we investigate the applicability of voxel-based dose prediction for head-and-neck cancer cases which have rather complicated anatomical structure and usually several PTVs with different prescription doses are presented. As noted above, the results shown in Fig. 5 and Table I indicate that the proposed method accurately predicts PTVs and OARs DVH curves. This method has the additional benefit of predicting the 3D dose distribution which provides dose information for all voxels. Table I illustrates the comparison of TPS calculated and predicted clinical indices for OARs and PTVs. We find that the predicted results for small volume OARs, including brainstem, left and right lens, vary slightly significant. Although the t-test results are statistically significant, the absolute differences are almost negligible and these Auto plans are all clinically acceptable. We believe that this phenomenon is caused by two reasons. First, this may due to the considerable variation in plan complexity and clinical priorities between patients in the training set. Second, the strategy we used in our network training process is too simple, in that it weights all voxels equally. This may degrade the results for small volume structures. Our future area of investigation is to find whether the predicted results can be improved if the optimized training set that has approximately consistent clinical priorities and plan qualities is applied to train the deep learning network. The proposed new auto-planning strategy uses the predicted 3D dose distribution as the objective function and the results come close to match the clinically acceptable plans without any post-optimization. Besides the target structure that is required for the matRad software, this method requires only the predicted dose distribution for optimization which indicates that numbers of structures created for dose shaping purpose can be reduced. As an orientation study, we only test the feasibility of this new automatic treatment planning strategy and the monitor units (MUs) of each Auto plan is not collected and compared because of the different machines in Pinnacle and matRad. We will try to input the commissioned beam data into matRad software, compute the MUs of each Auto plan, and compare them with the Pinnacle system in the future.
As shown in Table I , the differences between the predicted and automatic generated plan were not statistically significant for clinical indices of all targets and OARs except PTV 70. 4 . However, the absolute difference for PTV 70.4 is only 34 cGy (0.5%). This may have been caused by constraints of OARs that were adjacent to PTV 70.4 region and requires more samples in the training set to obtain a better dose distribution which has considered dose fall-off between PTV 70.4 and its adjacent OARs. Also, as stated previously, all voxels are equally weighted in our new optimization objective function, and this relatively simple strategy may also contribute to the differences in the PTV 70.4 region. Figure 6 indicates the dose distributions of Auto plan can reproduce the predicted results by adopting a simple objective function stated in Section 2.C. However, we cannot get a better plan by using this objective function since it tries to pull dose distribution to the predicted one. In other words, the best possible result obtained by using this objective function is the predicted dose distribution. We could adopt a more complex objective function similar to the DVH objective function, which pulls target dose higher and spares more OAR dose, to obtain a better Auto plan. This will be another major area of investigation in our future work.
The proposed automated treatment planning strategy opens up the possibility of a voxel-by-voxel cost optimization system and eliminates the need to convert a desired dose distribution to DVH values. In the future, it would be a dramatic improvement if a physician's clinical intent could be directly reflected in the target dose for each voxel through a treatment planning interface designed to make use of the predicted 3D dose distribution.
CONCLUSION
This paper demonstrates the feasibility of a new automated treatment planning strategy which includes the deep learning-based 3D dose distribution prediction and automatic plan generation based on the predicted dose distribution. The method can generate clinically acceptable treatment plans that are comparable to plans manually generated by dosimetrists. It has the potential to improve the quality and efficiency of treatment planning for radiotherapy. 
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